Innovative R&D Focus NGM Bio’s biology-centric drug discovery approach and in-house pipeline development position the company as a leader in innovative therapeutic solutions, providing opportunities to offer specialized research tools, collaborative services, or custom bioprocessing partnerships.

Growth Through Clinical Trials With four programs currently in active clinical development and recent funding rounds to support pivotal studies, NGM Bio is seeking advanced clinical trial support, regulatory consulting, and patient recruitment services to accelerate their pipeline progress.

Leadership Expansion Recent high-level hires including a new Chief Medical Officer and SVP of Clinical Development indicate a commitment to expanding clinical capabilities, opening sales opportunities for medical staffing, clinical technology platforms, and data management solutions.

Funding & Strategic Partnerships The company’s successful Series A raise of $122M and strategic acquisitions suggest potential interest in additional investment, joint ventures, or licensing agreements with biotech suppliers, research organizations, and technology providers.

Focus on Rare Diseases NGM Bio’s strategic shift towards rare conditions with unmet needs presents opportunities to engage with niche biotech and healthcare service providers, offering tailored diagnostics, specialized laboratory equipment, or patient engagement platforms.